InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
6
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-34.1%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Cruz Brandon M., Directeur de la Stratégie. Director active across 1 company, notably GoHealth, Inc.. Aggregated, 8 disclosures have been published. Split: 6 buys · 0 sell. Total volume traded: €5m. Activity tracked since 16 August 2021. The latest transaction was disclosed on 11 February 2023 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
1,039 shares@ US$16.810.3% of flowClass A Common StockSEC:0001808220-23-000024:0
15,575 shares@ US$1.880.10% mcap0.5% of flowClass A Common StockSEC:0001808220-22-000007:0
530,000 shares@ US$3.65933.9% of flowClass A Common StockSEC:0001808220-21-000070
Ideal exit: 19 Aug 2022 (T+270)
530,000 shares@ US$3.6596.86% mcap34.1% of flowClass A Common StockSEC:0001808220-21-000070:0
Ideal exit: 19 Aug 2022 (T+270)
24,210 shares@ US$4.6830.39% mcap1.9% of flowClass A Common StockSEC:0001808220-21-000044:0
Ideal exit: 15 May 2022 (T+270)
24,210 shares@ US$4.6831.9% of flowClass A Common StockSEC:0001808220-21-000044
Ideal exit: 15 May 2022 (T+270)
174,827 shares@ US$4.6852.78% mcap13.8% of flowClass A Common StockSEC:0001808220-21-000036:0
Ideal exit: 13 May 2022 (T+270)
174,827 shares@ US$4.68513.7% of flowClass A Common StockSEC:0001808220-21-000036
Ideal exit: 13 May 2022 (T+270)
8 of 8 declarations
About Cruz Brandon M.
Brandon M. Cruz is the Chief Strategy Officer at GoHealth, Inc., a health technology company. In this role, he is responsible for defining and implementing strategies that drive growth and innovation. With a strong background in the healthcare sector, he plays a crucial role in aligning business initiatives with the company's strategic objectives.
